747 related articles for article (PubMed ID: 19919986)
1. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
[TBL] [Abstract][Full Text] [Related]
2. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
3. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure.
Charach G; George J; Afek A; Wexler D; Sheps D; Keren G; Rubinstein A
J Card Fail; 2009 Nov; 15(9):770-4. PubMed ID: 19879463
[TBL] [Abstract][Full Text] [Related]
6. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
[TBL] [Abstract][Full Text] [Related]
7. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K
J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of plasma renin activity in heart failure.
Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
10. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
[TBL] [Abstract][Full Text] [Related]
11. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
12. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
13. The role of BNP testing in heart failure.
Doust J; Lehman R; Glasziou P
Am Fam Physician; 2006 Dec; 74(11):1893-8. PubMed ID: 17168346
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
Pimenta J; Paulo C; Gomes A; Silva S; Rocha-Gonçalves F; Bettencourt P
Liver Int; 2010 Aug; 30(7):1059-66. PubMed ID: 20492497
[TBL] [Abstract][Full Text] [Related]
15. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
[TBL] [Abstract][Full Text] [Related]
16. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
[TBL] [Abstract][Full Text] [Related]
17. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
18. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
[TBL] [Abstract][Full Text] [Related]
19. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
[TBL] [Abstract][Full Text] [Related]
20. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
